Jan Kronish, MD
Ophthalmology · Delray Beach, FLNPI 1720189699
Payments from drug & device makers
Across 51 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$503
- AbbVie$110
- Johnson & Johnson Surgical Vision, Inc.$107
- Dompe US, Inc.$107
- Astellas Pharma US Inc$54
- Sun Pharmaceutical Industries Inc.$47
- plus $360 from 14 others
What the payments were for
- Food & beverage$1,23896%
- Education$292%
- Gifts$192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 18 | $503 |
| AbbVie(2 entities) | 7 | $110 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $107 |
| Dompe US, Inc. | 2 | $107 |
| Astellas Pharma US Inc | 2 | $54 |
| Sun Pharmaceutical Industries Inc. | 3 | $47 |
| Tarsus Pharmaceuticals, Inc. | 2 | $44 |
| Bausch & Lomb Americas Inc. | 3 | $42 |
| Novartis | 2 | $33 |
| Ocular Therapeutix, Inc. | 1 | $29 |
| Glaukos Corporation | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Thea Pharma Inc. | 1 | $24 |
| Alimera Sciences, Inc. | 1 | $23 |
| Oyster Point Pharma, Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Rayner Intraocular Lenses Limited | 1 | $19 |
| Eyevance Pharmaceuticals LLC | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
| NEW World Medical,inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$247
- Tecnis Symfony IOL$107
How this compares
$1,287 in reported general payments places this provider in the 35th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 331 | $13,732 |
| Cyclosporine | 13 | $4,777 |
| ErythromycinErythromycin Base | 439 | $3,919 |
| Fluorometholone | 47 | $3,510 |
| Loteprednol Etabonate | 27 | $2,127 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 71 | $746 |
| Ketorolac Tromethamine | 42 | $634 |
| Doxycycline Hyclate | 39 | $587 |
| Cephalexin | 82 | $519 |
| Azithromycin | 18 | $211 |
| Ofloxacin | 18 | $197 |
| Methylprednisolone | 16 | $91 |
| Latanoprost | 19 | $80 |
| Brimonidine Tartrate | 14 | $43 |
| Timolol Maleate | 15 | $20 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Delray Beach
- Robert RadenDelray Beach$7.8M
- Bruce SegalDelray Beach$4.7M
- David EichenbaumSt Petersburg$34.4M
- Carl DanzigPompano Beach$5.3M
- Cathleen McCabeBradenton$4.6M
- Ivan SunerTampa$3.7M
- Sunir JoshiFt Lauderdale$3.7M
- Harold BrooksTallahassee$3.5M
- Matthew CunninghamOrlando$2.9M
- Benjamin ThomasJacksonville$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.